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Abstract
Background: Prognosis in pulmonary hypertension (PH) is related to right ventricular (RV) function. Quantification
of RV mechanics may offer additive value. The objective of our study is to determine the feasibility and clinical and
prognostic value of RV strain analysis by cardiovascular magnetic resonance (CMR) based feature tracking (FT) in PH.
Methods: We retrospectively enrolled 116 patients (age 52.2 ± 12 years, 73.6 % women) referred to CMR for PH
evaluation who underwent right heart catheterization within 1 month. Using dedicated FT software, peak global
longitudinal and circumferential RV strain and strain rates (GLS, GCS, GLSR, and GCSR, respectively) were quantified
from standard cine images. Using multivariate regression analysis, we evaluated the associations of strain with a
composite endpoint of death, lung transplantation, or functional class deterioration.
Results: RV strain analysis was feasible in 110 (95 %) patients. Patients were classified into: Group A (no PH, normal
right ventricular ejection fraction [RVEF]; n = 17), Group B (PH, normal RVEF; n = 26), or Group C (PH, abnormal RVEF;
n = 67). All strain and strain rate values were reduced in Group C. Furthermore, GCSR was significantly reduced in
Group B (-0.92 [-1.0/-0.7]; p < 0.001) compared to Group A (-1.12 [-1.3/-0.9]; p < 0.001). After adjustment for six
clinically meaningful covariates, GLS (hazard ratio 1.06; p = 0.026), GLSR (hazard ratio 2.52; p = 0.04), and GCSR
(hazard ratio 4.5; p = 0.01) were independently associated with the composite endpoint. GCSR successfully
discriminated patients with and without events (p = 0.01).
Conclusions: Quantification of RV strain with CMR-FT is feasible in the majority of patients, correlates with disease
severity, and is independently associated with poor outcomes in PH.
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Background
Pulmonary hypertension (PH) is a condition characterized
by increased pressure and resistance in the pulmonary
vasculature and is associated with high mortality. The prog-
nosis of this disorder is directly related to right ventricular
(RV) function, one of the main predictors of long-term out-
come in patients with PH irrespective of its etiology [1–3].
Thus, accurate, reproducible, and clinically meaningful
noninvasive methods for the detection and quantification
of global or regional RV systolic function are important in
the assessment of PH.
Echocardiography is the most widely available imaging
modality for the evaluation of RV structure and function;
however, image quality of the RV is often inadequate,
and quantification can be subjective and limited by the
complex geometry of this chamber [4]. Cardiovascular
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magnetic resonance (CMR) has emerged as the gold stand-
ard for the quantification of RV volume and ejection frac-
tion (RVEF), particularly using steady-state free precession
(SSFP) cine imaging [5]; however, other metrics of RV func-
tion such as quantification of myocardial deformation may
allow detection of early abnormalities and provide inde-
pendent prognostic information, as demonstrated in echo-
cardiographic studies [6–8].
Recently, a novel method of “feature tracking” (FT) that
allows quantification of myocardial deformation from
CMR cine images without the need for additional imaging
or lengthy analysis has been developed [9, 10]. Of note,
CMR-FT has been validated against myocardial tagging
for left ventricular (LV) strain analysis [11, 12] and re-
cently against RV speckle tracking imaging for RV longitu-
dinal strain evaluation in tetralogy of Fallot patients [13].
To the best of our knowledge, the significance of quanti-
fying RV myocardial deformation in patients with PH using
CMR-FT has not been investigated. Therefore, the aims of
this study were to 1) evaluate the feasibility of performing
routine RV strain analysis using CMR-FT, 2) characterize
the pattern and severity of RV strain abnormalities in pa-
tients with PH, and 3) establish the prognostic significance
of RV strain measurements in PH.
Methods
Patient population
We retrospectively evaluated patients referred for CMR
evaluation of known or suspected chronic PH who also
underwent right heart catheterization (RHC) within
1 month of the CMR. The presence of PH was defined
as a mean pulmonary artery pressure >25 mm Hg at
RHC [14]. Patients without PH and with RV dysfunction
(RVEF <50 %) [15] suggestive of underlying myocardial
disease, patients with cardiac shunts, or those with PH
Groups 2-4 were excluded, resulting in 116 patients
from Group 1 (pulmonary arterial hypertension) and
Group 5 (unclear multifactorial mechanisms) of the PH
Nice Classification [2]. After exclusion of 6 patients with
inappropriate image quality due to arrhythmia, 110 pa-
tients were included in the present analysis. Of those, 17
patients who had no PH on RHC and a normal echocar-
diogram and CMR were used as controls.
Medical records were reviewed for clinical, hemodynamic,
and CMR data. In addition, a composite endpoint of clinical
worsening was recorded, defined as 1) all-cause mortality, 2)
lung transplantation, or 3) worsening of New York Heart
Association (NYHA) functional class. Only the most severe
endpoint (death > transplant >worsening NYHA class) was
used for analysis if more than one outcome occurred in the
same patient. All deaths were confirmed by the Social Secur-
ity Death Index. The Mount Sinai Institutional Review
Board (New York, NY, USA) approved the study with a
waiver of informed consent.
CMR acquisition
CMR studies were performed on a 1.5 Tesla (MAGNE-
TOM Sonata or MAGNETOM Avanto, Siemens Medical
Solutions, Erlanger, Germany) or 3.0 Tesla (Ingenia Philips
Healthcare, Best, The Netherlands) clinical magnets using
12- or 32-channel phased-array surface coils as receivers.
Images were acquired during end-expiratory breath holds
with retrospective electrocardiographic or pulse gating.
Standard long-axis 4-chamber cine images were obtained
using SSFP imaging. In addition, contiguous cine short-
axis slices covering both ventricles from base to apex were
also acquired with cine SSFP (typical acquisition parame-
ters: repetition time/echo time 3.2–3.9/0.6–2 ms, flip
angle 45–90°, slice thickness 6 mm, in-plane spatial reso-
lution 1.5–2 mm, temporal resolution 33–45 ms, 25–30
reconstructed cardiac phases). RV and LV end-diastolic
and end-systolic volumes and ejection fractions were
obtained according to the Simpson method using special-
ized software (Argus, Siemens Medical Solutions or Ex-
tended MR WorkSpace, Philips Healthcare). To calculate
RV mass, RV free wall epicardial and endocardial borders
were traced on each end-diastolic short-axis. Volumes and
mass were indexed to body surface area. Right atrial area
was planimetered in the 4-chamber view in the phase
showing maximal atrial dimension [16].
Late gadolinium enhancement (LGE) short and long
axis images were obtained approximately 10 min after in-
fusion of 0.2 mmol/kg of gadolinium-diethylenetriamine
pentaacetic acid (Magnevist, Berlex Laboratories, Mont-
ville, New Jersey) using a T1-weighted, 2-dimensional, fast
gradient echo sequence. The presence of LGE in the
interventricular septum and/or RV insertion points was
assessed visually as previously described [17]. No pa-
tient had LGE in other portions of the left ventricle.
CMR-FT analysis
Strain imaging measures the percentage change in myocar-
dial deformation, while its derivative, strain rate, measures
the rate of myocardium deformation over time (s-1) [18].
Myocardial fiber lengthening (expansion), by convention, is
represented as a positive value for strain, while shortening
(compression) is represented by a negative value. Myocar-
dial fibers can deform in 3 spatial directions or planes (x, y,
and z axis) (Fig. 1), respectively measured as circumferen-
tial, longitudinal, and radial strain.
CMR-FT Diogenes software (2D CPA MR, version
1.1.2.36; TomTec Imaging Systems GmbH, Unterschleis-
sheim, Germany) was used for deformation analysis on 3
short-axis (basal, mid, and apical levels) and a 4-chamber
view. To ensure a standardized analysis for each patient,
the basal slice in short axis view was defined as the first
slice below the atrioventricular level showing circumferen-
tial LV myocardium, the mid-ventricular slice was local-
ized at the level of both papillary muscles, and the apical
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slice at an apical location with the same distance to the
mid-ventricular level as the basal slice. We used end dia-
stolic phase to start the analysis. As described previously
[19], RV endocardial contours were traced manually on
one frame and then the software automatically propagated
the contour throughout the remainder of the cardiac
cycle. The contours were checked and manually adjusted
if needed. RV global longitudinal strain (GLS) and strain
rate (GLSR) were calculated as the average of peak systolic
values from 2 basal, 2 mid, and 2 apical segments obtained
from the 4-chamber view (Fig. 2). RV global circumferen-
tial strain (GCS) and strain rate (GCSR) were calculated
as the average of 4 basal, 4 mid, and 4 apical segmental
peak systolic values obtained from the short-axis views. In
this study we decided not to evaluate radial deformation
because it is our experience, as well as others’ [20], that
this parameter is less reliably quantified using CMR-FT.
The entire analytic process required approximately 4 min.
A single investigator (M.E.M.S) reviewed all CMR stud-
ies and performed the image analyses as detailed above.
To assess intra-observer variability, the same investigator
re-analyzed 20 studies 2 weeks after the first analysis. A
second investigator (K.M) also evaluated 20 studies for the
assessment of inter-observer reproducibility.
RHC protocol
RHC was performed under fluoroscopic guidance using a
Swan-Ganz catheter. Zero-pressure calibration was per-
formed at the level of the mid-axillary line with the patient
in the supine position. Baseline measurements included
mean right atrial pressure, mean and systolic pulmonary
artery pressures, pulmonary artery wedge pressure, cardiac
index (obtained by thermodilution), pulmonary oxygen
Fig. 1 Schematic representation of myocardial fiber orientation and
deformation in 3 orthogonal axis
Fig. 2 RV longitudinal strain analysis obtained from a four chamber view. Examples of longitudinal strain measurements in a patient without
(bottom) and with pulmonary hypertension (top). The dotted line represents the average strain of the four segments
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Table 1 Demographic, clinical, hemodynamic and cardiac magnetic resonance data according to the presence of pulmonary
hypertension and right ventricular ejection fraction
Variable Total
(n = 110)
Group A (No PH and
RVEF ≥50 %) (n = 17)
Group B (PH and RVEF
≥50 %) (n = 26)
Group C (PH and RVEF
< 50 %) (n = 67)
P
Demographic data
Age (yrs) 52.2 ± 12 52.6 ± 13 55 ± 12 51 ± 12 0.37
Female sex 81 (73.6 %) 15 (88.2 %) 22 (84.6 %) 44 (65.7 %) 0.06
Body surface area (m2) 1.79 ± 0.23 1.74 ± 0.17 1.76 ± 0.23 1.8 ± 0.24 0.369
Cardiovascular risk factors
Diabetes 12 (10.9 %) 0 4 (15.4 %) 8 (11.9 %) 0.26
Hypertension 24 (21.8 %) 3 (17.6 %) 8 (30.8 %) 13 (19.4 %) 0.44
Hyperlipidemia 17 (15.5 %) 3 (17.6 %) 4 (15.4 %) 10 (14.9 %) 0.96
Smoking history 8 (7.3 %) 0 3 (11.5 %) 5 (7.5 %) 0.24
Medications
Beta blockers 14 (12.7 %) 1 (5.8 %) 2 (8 %) 11 (18 %) 0.12
Calcium channel blockers 34 (30.9 %) 0 16 (61.5 %) 18 (26.9 %) <0.001** ŧ
Diuretics 66 (60 %) 2 (13.3 %) 13 (52 %) 51 (83.6 %) <0.001** ŧ&
Anticoagulants 38 (34.5 %) 2 (11.7 %) 8 (30.7 %) 28 (41.7 %) 0.053&
ERAs 31 (28.2 %) 0 4 (15.7 %) 27 (40.2 %) <0.001ŧ&
Prostanoids 34 (30.9 %) 0 8 (30.7 %) 26 (38.8 %) 0.03&
PDIs 48 (43.6 %) 0 11 (42.3 %) 37 (55.2 %) <0.001**&
Digoxin 38 (34.5 %) 2 (11.7 %) 4 (15.4 %) 32 (47.7 %) 0.001ŧ &
Corticosteroids 25 (22.7 %) 2 (11.7 %) 4 (15.4 %) 19 (28.3 %) 0.201
NYHA functional class ≥2 90 (81.8 %) 2 (11.7 %) 22 (84.6 %) 62 (92.5 %) <0.001**&
Hemodynamic data
Systolic aortic pressure (mm Hg) 122.1 ± 19 122.7 ± 20.3 132 ± 19.2 118.2 ± 18.1 0.009ŧ
PAWP (mm Hg) 9.8 ± 4.1 8.5 ± 2.8 11.5 ± 4.7 9.55 ± 4 0.05
Cardiac index (L/min/m2) 3.2 ± 1.1 3.71 ± 1 3.77 ± 1.5 2.91 ± 0.9 0.001ŧ&
Systolic PA pressure
(mm Hg)
63.6 ± 24.7 29.6 ± 3.8 50.8 ± 13.1 72.1 ± 27.9 <0.001&
Mean PA pressure
(mm Hg)
39.6 ± 14.9 17.1 ± 3.3 36.3 ± 10.6 46.6 ± 11.7 <0.001**ŧ&
RA pressure (mm Hg) 6 [23.1–35.6] 4 [3–6] 6 [4–10] 7 [5–14] 0.006**&
PVRI (Woods units × m2) 5.8 [2.7–9.3] 1.8 [1.2–2.4] 4 [2.1–8] 6.9 [5–10.4] <0.001**ŧ&
PA oxygen saturation (%) 64.7 ± 10.97 72.6 ± 4.8 68.6 ± 6.9 61.1 ± 11.8 <0.001ŧ&
Cardiac magnetic resonance
LVEF (%) 58.9 ± 9.8 63.3 ± 6 64.6 ± 5.2 55.5 ± 10.5 <0.001ŧ&
LVEDVi (mL/m2) 66.6 ± 17.4 69 ± 12.5 73 ± 25 63 ± 18.5 0.07
LVESVi (mL/m2) 27.6 ± 9.9 25.3 ± 6.6 26.1 ± 7 28.2 ± 11.3 0.30
RVEF (%) 42.15 ± 13.7 57.5 ± 4.6 55.2 ± 4.8 33.1 ± 9.4 <0.001ŧ&
RVEDVi (mL/m2) 98.8 [75.3–127] 73.1 [57.6–81.1] 85.4 [71.7–99] 116.4 [98–156] <0.001**ŧ&
RVESVi (mL/m2) 56 [36.9–87.3] 28.7 [23.1–35.6] 39.6 [33.8–47.9] 78.6 [56.1–103] <0.001**ŧ&
RV mass index (g/m2)* 25 [17.4–33] 15.5 [13.4–17.4] 18.8 [14.1–24.3] 30.2 [23.7–35.6] <0.001**ŧ&
LGE 44 (40 %) 1 (5.9 %) 3 (11.5 %) 38 (56.7 %) <0.001ŧ&
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saturation, and pulmonary vascular resistance index. Sys-
tolic aortic pressure was measured by sphygmomanometry.
We classified patients according to the results of the
RHC and CMR into one of three groups: A (control group;
no PH and normal RVEF), B (PH and normal RVEF), or C
(PH and decreased RVEF [<50 %]).
Statistical analysis
Continuous variables were expressed as mean ± SD or me-
dian [interquartile range] depending on their distribution,
and categorical variables were described as total number
(percentage). When comparing patients with and without
PH, the χ2 test and Fisher exact test were used for categor-
ical variables where appropriate. Differences in normally
and non-normally distributed continuous variables were
established using a 2-tailed unpaired Student t test and
Mann-Whitney U test, respectively, or in cases involving
multiple groups, the ANOVA test and Kruskal Wallis test,
respectively. Correlations between hemodynamic variables
and those derived from CMR-FT strain were assessed by
Pearson r or Spearman rho correlation coefficients, as ap-
propriate. To test for intra- and inter-observer variability
in strain measurements, we used Bland-Altman plots and
intraclass correlation coefficient with a 2-way random
model of absolute agreement.
CMR global strain parameters as well as other clinical,
morphological, and hemodynamic variables significantly as-
sociated with the combined endpoint were identified. After
discarding variables that showed collinearity, multivariate
models were created using a selection of 6 clinically rele-
vant variables in order to avoid overfitting. Then individual
strain parameters were separately added into the models,
and a Cox regression model was derived with a backward
stepwise method for each strain/strain rate. Hereof, vari-
ables independently associated with the endpoint and pre-
dictive models were obtained. Results were presented as
hazard ratios with 95 % confidence intervals. Receiver oper-
ating characteristic (ROC) curves were used to determine
the accuracy of the global strain parameters in predicting
the primary combined endpoint (death, transplant, or wors-
ening of NYHA functional class). In addition, associations
between the strain parameters and time to the primary end-
point were evaluated with adjusted survival Cox analysis
using the best cut-off value derived from the ROC
curves. Results were considered statistically significant
when the 2-tailed p value was <0.05. Analyses were per-
formed using SPSS 18.0 (IBM, Armonk, NY, USA).
Results
Patient characteristics
Demographic, clinical, hemodynamic, and CMR-derived
parameters for the whole sample divided according to
the presence or absence of PH and RV dysfunction are
shown in Table 1. Among 110 patients, PH was absent
in 17 (15.5 %) and present in 93 (84.5 %). There were 70
patients (75 %) with pulmonary arterial hypertension in
PH Group 1 and 23 patients (25 %) in PH Group 5. The
etiologic disease responsible for the placement in Group
1 was connective tissue disease in 25 patients, idiopathic
PH in 23, portopulmonary syndrome in 11, human im-
munodeficiency virus infection in 10, and anorexigen
abuse in 1. Among the PH Group 5 patients, sarcoidosis
was the cause in 23 and sickle cell disease was the cause
in 2. Diseases underlying the presumed diagnosis of PH
in the 17 control subjects (Group A) included sclero-
derma in 5, sarcoidosis in 3, hepatitis in 2, and no dis-
ease in 7. Among those with PH, 26 patients had normal
RVEF and 67 had decreased RVEF (comprising Groups
B and C, respectively).
As shown in Table 1, there were no differences among
Groups A, B, and C with respect to age, sex, body surface
area, or cardiovascular risk factors. Patients with PH were
more likely to be symptomatic (NYHA functional class ≥2)
and to use diuretics, phosphodiesterase inhibitors, and
prostanoids. Those with preserved RVEF used calcium
channel blockers more often, while those with RV dysfunc-
tion were more frequently treated with endothelin receptor
antagonists and digoxin. As expected, mean pulmonary
artery pressure and pulmonary vascular resistance index
increased progressively from Group A to Group C. Pa-
tients with PH and RV dysfunction had lower cardiac
index and pulmonary artery oxygen saturation, larger and
Table 1 Demographic, clinical, hemodynamic and cardiac magnetic resonance data according to the presence of pulmonary
hypertension and right ventricular ejection fraction (Continued)
RA area (mm2) 24.54 ± 8.9 17.9 ± 3.3 21.9 ± 7 27.1 ± 9.5 0.001ŧ&
Clinical outcomes
Death/transplant/worse NYHA class 78 (70.9 %) 4 (23.5 %) 12 (46.1 %) 62 (92.5 %) <0.001ŧ&
Values are mean ± standard deviation, n (%), or median [interquartile range]
ERA endothelin receptor antagonist, LGE late gadolinium enhancement, LVEF left ventricular ejection fraction, LVEDVi left ventricular end-diastolic volume index, LVESVi
left ventricular end-systolic volume index, NYHA New York Heart Association, PA pulmonary artery, PAWP pulmonary artery wedge pressure, PDI phosphodiesterase
inhibitor, PVRI pulmonary vascular resistance index, RA right atrium, RVEDVi right ventricular end-diastolic volume index, RVEF right ventricular ejection fraction, RVESVi
right ventricular end-systolic volume index
**Statistically significant differences between group A (control group) and group B
ŧ Statistically significant differences between group B and group C
& Statistically significant differences between group A and group C
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more hypertrophic RV, larger right atrial dimensions,
smaller RV and LV ejection fractions, and more frequent
LGE.
RV strain analysis
Global RV strain and strain rate values for the whole
sample and Groups A-C are presented in Table 2. All
strain and strain rates were reduced in patients with PH
and impaired RVEF in comparison with those without
PH and those with preserved RVEF. In addition, GCSR
was significantly reduced in the group with PH and pre-
served RVEF group compared to the control group
(Table 2 and Fig. 3).
CMR-FT strain measurements demonstrated low inter-
and intra-observer variability as indicated by the intraclass
correlation coefficient (0.96/0.99; 0.94/0.98; 0.96/0.97; and
0.96/0.98 for GLS, GCS, GLSR, and GCSR, respectively;
Additional file 1: Table S1 and Additional file 2: Figure S1).
Correlations between RV deformation and disease severity
Correlations between RV strain/strain rates and
hemodynamic and CMR measurements are shown in
Additional file 3: Table S2. For these analyses, the absolute
values (without the negative sign) of deformation indices
were used. Overall, there were strong and moderate positive
correlations of global strains and strain rates, respectively,
with RVEF, and moderate negative corrrelations with RV
Table 2 Global right ventricular strain and strain rate
Strain Parameter Total (n = 110) Group A (No PH and
RVEF ≥50 %) (n = 17)
Group B (PH and RVEF
≥50 %) (n = 26)
Group C (PH and RVEF
< 50 %) (n = 67)
P
GLS (%) -15.85 ± 6.4 -22.10 ± 4.7 -20.10 ± 5.3 -12.56 ± 4.8 <0.001bc
GCS (%) -11.21 ± 4.9 -16.43 ± 4.7 -14.12 ± 3.5 -8.72 ± 3.5 <0.001bc
GLSR (s-1) -1.09 ± 0.4 -1.46 ± 0.4 -1.33 ± 0.3 -0.89 ± 0.3 <0.001bc
GCSR (s-1) -0.76 [-0.9 - (-0.5)] -1.12 [-1.3 - (-0.9)] -0.92 [-1.0 - (-0.7)] -0.63 [-0.7 - (-0.4)] <0.001abc
Values are mean ± standard deviation or median [interquartile range]
GCS global circumferential strain, GCSR global circumferential strain rate, GLS global longitudinal strain, GLSR global longitudinal strain rate, PH pulmonary
hypertension, RVEF right ventricular ejection fraction
Continuous variables are expressed as mean ± standard
aStatistically significant differences between group A (control group) and group B
bstatistically significant differences between group C and group B
cstatistically significant differences between group A and group C
Fig. 3 Right ventricular global circumferential strain rate (GCSR) values in the three groups. Among patients with preserved right ventricular ejection
fraction, there was a significantly lower value for those with pulmonary hypertension (PH) (Group B) compared to those without PH (Group A)
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mass index. There were also moderate negative correlations
with RV volumes and mean pulmonary artery pressures,
and weaker correlations with right atrial size and remaining
hemodynamic parameters (except between GCS/GCSR and
cardiac index). In addition, all deformation indices were
reduced in patients with LGE (Additional file 4: Table S3).
Global RV strain parameters and clinical outcome
Median duration of follow-up was 730 days (range 190
to 1585 days). There were 78 events: 38 deaths (34.5 %),
2 lung transplantations (1.8 %), and 38 cases of NYHA
class worsening (34.5 %). Patients with PH and RVEF
<50 % had a greater incidence of events (p < 0.001) com-
pared to those with either PH and normal RVEF or no
PH. There was no statistically significant difference re-
garding the composite endpoint between Groups A and
B (Table 1).
The associations of all invasive and non-invasive vari-
ables with the combined endpoint are reported in Table 3.
In brief, the medication use and functional class differed
between those who did or did not have events. Among
RHC parameters, systemic and pulmonary pressures, car-
diac index, pulmonary vascular resistance index, and pul-
monary oxygen saturation were associated with the primary
endpoint. Similarly, among CMR measurements, reduced
biventricular ejection fractions and LV end-diastolic vol-
ume, enlarged RV and right atrium, RV hypertrophy and
presence of LGE each were more common in patients
experiencing events. All strain and strain rates were also
decreased in the event-positive group.
From non–strain-related variables associated with out-
comes (Table 3) the following were selected for inclusion
in the Cox analysis based on their univariate associations
and known clinical value: NYHA class ≥2, cardiac index,
pulmonary artery oxygen saturation, mean pulmonary
artery pressure, RV mass index, and RVEF. We did not
include RV end-diastolic volume index, systolic pulmon-
ary pressure, or pulmonary vascular resistance for multi-
variate analysis since they showed collinearity with
previous variables, and to avoid model overfitting. Table 4
shows the final predictive models with the correspond-
ing adjusted hazard ratios obtained when each global
strain parameter was introduced into the model. When
the strain parameters were analyzed as continuous vari-
ables, GLS (together with cardiac index, RV mass index
and mean pulmonary artery pressure), GLSR (together
with cardiac index and RV mass index), and GCSR (to-
gether with cardiac index, RV mass index and mean
pulmonary artery pressure) were each independently
associated with the combined endpoint, whereas GCS
was not. GLS, GLSR, GCR and GCSR cut-off points,
obtained from optimal values in the ROC curves (GLS
-17 %, GLSR -1.1 s-1, GCS -12 %, and GCSR -0.8 s-1)
were able to differentiate patients that presented the











Age (yrs) 53 ± 12 50 ± 12 0.35
Sex (female) 54 (69.2 %) 27 (84.4 %) 0.15
Body surface area (m2) 1.8 ± 0.25 1.7 ± 0.22 0.45
Use of medication 71 (91 %) 10 (31 %) <0.001
Smoking 5 (6.4 %) 3 (9.4 %) 0.059
NYHA class ≥2 71 (91 %) 3 (9.3 %) <0.001
Systolic aortic pressure
(mm Hg)
119 ± 18 127 ± 20.5 0.03
PAWP (mm Hg) 9.7 ± 4.2 10.1 ± 4.7 0.38
Cardiac index (L/min/m2) 3 ± 1 3.6 ± 1.57 0.04
Systolic PA pressure
(mm Hg)
73.2 ± 20.3 58.1 ± 19.1 0.004
Mean PA pressure
(mm Hg)
44.6 ± 11.8 27.5 ± 12.2 <0.001
RA pressure 9.4 ± 7.9 6.4 ± 3.0 0.18
PVRI (Woods units x m2) 6.6 [3.9–10.3] 2.4 [1.5–6.8] 0.004
PA sat (%) 62 ± 11.6 71 ± 4.8 0.002
LVEF (%) 56.9 ± 10.8 62.5 ± 5.5 <0.001
LVEDVi (mL/m2) 64 ± 18 72 ± 14 0.036
LVESVi (mL/m2) 27.7 ± 10.9 27.3 ± 6.7 0.82
RVEF (%) 37.38 ± 12.4 53.7 ± 9.4 <0.001
RVEDVi (mL/m2) 112 [87.6–144.6] 75 [69.9–97.9] 0.01
RVESVi (mL/m2) 70 [44.9–95.4] 35.2 [28.7–
48.3]
<0.001
RV mass index (gr/m2) 29.8 [23.5–35.1] 18.4 [14.3–
22.9]
0.001
LGE 39 (50 %) 5 (15.6 %) 0.01
RA area 26 ± 9.4 20 ± 5.8 0.001
Strain parameters
GLS (%) - 13.57 ± 5.5 -19.01 ± 5.7 <0.001
GCS (%) -9.6 ± 4.2 -12.58 ± 3.7 0.007
GLSR (s-1) -0.94 ± 0.3 -1.33 ± 0.4 <0.001
GCSR (s-1) -0.67 [-0.7 - (-0.4)] -0.92 [-1.1 -
(-0.8)]
<0.001
Values are mean ± standard deviation, n (%), or median [interquartile range]
GCS global circumferential strain, GCSR global circumferential strain rate, GLS
global longitudinal strain, GLSR global longitudinal strain rate, LGE late
gadolinium enhancement, LVEF left ventricular ejection fraction, LVEDVi left
ventricular end-diastolic volume index, LVESVi left ventricular end-systolic
volume index, NYHA New York Heart Association, PA pulmonary artery, PAWP
pulmonary artery wedge pressure, PVRI pulmonary vascular resistance index,
RA right atrium, RVEDVi right ventricular end-diastolic volume index, RVEF right
ventricular ejection fraction, RVESVi right ventricular end-systolic volume index
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combined end-point during the follow-up, as shown in
Kaplan-Meyers curves (Fig. 4). However, only GCSR
cut-off point remained as independent outcome pre-
dictor after adjusting in the multivariate model (Fig. 5).
An additional multivariate analysis was also performed
including guideline-recommended variables for prognosti-
cation in PH [21]: NYHA class ≥2, cardiac index, pulmon-
ary artery oxygen saturation, right atrial pressure and
RVEF. GLS (together with cardiac index), GLSR (together
with RVEF), and GCSR (together with cardiac index) were
each independently associated with the combined end-
point, and again GCS was not (Additional file 5: Table S4).
Finally, when all strain parameters were forced together
into the first model, the final variables retained were
GCSR, cardiac index, mean pulmonary artery pressure,
and RV mass index (Additional file 6: Table S5).
Discussion
The major findings of our study are as follows: 1) System-
atic evaluation of RV strain in PH with CMR-FT is feasible
and reproducible, 2) measures of RV strain correlate with
disease severity, 3) reduced RV strain indices are associ-
ated with subsequent clinical deterioration, and 4) GCSR
specifically is associated with outcomes even after adjust-
ment for other prognostic predictors in PH.
RV function is the main predictor of survival in PH
patients [1–3]. While echocardiography remains the most
commonly used modality to assess this factor in clinical
practice, CMR is today considered the gold standard for
the quantification of RV volumes and ejection fraction [5];
however, other measures of myocardial deformation may
be of interest and provide additive information regarding
RV performance. Myocardial tissue tagging with CMR is
considered the noninvasive reference method to assess LV
regional deformation [22, 23]. Although feasible [24], its
application to the right chamber is limited mostly because
of the relatively thin chamber wall, and the method re-
quires laborious offline post-processing analysis. In con-
trast to conventional tagging, strain-encoded CMR is an
alternative technique that provides direct myocardial
strain imaging, and its capability of quantifying RV strain
in PH has been reported [25, 26]. However, the sequence
may not be widely available, and additional scanning is
required. Therefore, a method like FT that can be applied
in routinely acquired cine images can be potentially more
practical and time saving.
CMR-FT of the RV has been successfully used to demon-
strate RV dysfunction in congenital heart disease [13, 27]
and arrhythmogenic RV dysplasia [28] with good inter-
study and inter-observer reproducibility for RV global lon-
gitudinal strain measures. More recently, Ohyama et al.
[19] quantified RV longitudinal strain from cine images in
26 patients with PH using a different pixel-based multi-
modality tissue tracking method. They validated it against
strain encoded imaging and also reported high reproduci-
bility, although they could not show differences with nor-
mal volunteers. In our much larger series of 116 patients,
strain could not be evaluated only in 6 patients (5 %). In
addition, we were able to demonstrate significant reduc-
tions in GLS, GCS, GLSR, and GCSR compared with indi-
viduals lacking PH. Similar to Ohyama and colleagues,
reductions in strain parameters correlated with disease se-
verity whether measured as impairment in hemodynamics
or abnormalities in right heart chambers. Importantly,
decreased myocardial deformation was already noted in the
presence of PH alongside preserved RVEF, although this
reduction reached statistical significance in comparison
with individuals without PH only for GCSR, perhaps due to
sample size limitations. This finding indicates a potential
role for this parameter for noninvasive detection of PH or
of early RV decompensation.
To our knowledge, this is the first study to show the
relationship between CMR-FT-derived strain analysis
and outcomes in patients with PH. After adjustment for
6 covariates with known clinical and prognostic value
(namely functional class, cardiac index, pulmonary artery
oxygen saturation, mean pulmonary artery pressure, RV
mass index, and RVEF), GLS, GLSR, and GCSR remained
independently associated with the combined endpoint of
death, lung transplantation, or decrease in NYHA class.
Our findings are consistent with those reported in the
Table 4 Cox proportional adjusted hazard ratio for final
multivariate models of each RV strain parameter
Models Hazard ratio 95 % Confidence Interval P
GLS 1.06 1–1.12 0.026
Cardiac index 0.59 0.4–0.79 0.030
RV mass index 1.02 1–1.04 0.006
Mean PA pressure 0.97 0.95–0.99 0.02
RVEF 0.97 0.94–0.99 0.03
Cardiac index 0.66 0.49–0.90 0.009
RV mass index 1.02 1–1.04 0.02
Mean PA pressurea 0.97 0.95–0.99 0.02
GLSR 2.52 1.03–6.1 0.04
Cardiac index 0.65 0.48–0.89 0.008
RV mass index 1.03 1.01–1.05 0.033
GCSR 4.5 1.3–15.6 0.01
Cardiac index 0.61 0.46–0.81 0.001
RV mass index 1.02 1–1.04 0.006
Mean PA pressure 0.97 0.95–0.99 0.01
aModel including global circumferential strain, not shown
GCSR global circumferential strain rate, GLS global longitudinal strain, GLSR global
longitudinal strain rate, PA pulmonary artery, RVEF right ventricular ejection fraction
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echo literature using speckle-tracking based analysis of
RV deformation. Haeck et al evaluated 150 patients with
PH and demonstrated that RV GLS is a significant tripled
determinant of all-cause mortality risk compared to pa-
tients with higher GLS (threshold of < −19 %) [7]. Sachdev
et al also found that patients with PH and lower RV strain
and strain rate values had poorer survival [29]. In a pro-
spective study with a large cohort of 575 patients, RV
strain predicted outcome independent of other clinical
and echocardiographic variables [8]. Interestingly, Harde-
gree et al performed a study to assess whether serial quan-
titative assessment of RV strain by speckle-tracking was
affected by PH-specific treatments and concluded that
strain imaging independently predicts clinical deterior-
ation and mortality in PH patients after the institution of
medical therapy [30]. Although GLS and GLSR were also
predictors of events in our study, probably reflecting the
larger dependence of the RV on longitudinal shortening
[31], survival Cox analysis demonstrated GCSR to be su-
perior in identifying patients at heightened risk of events.
Strain rate describes the degree of change in myocardial
deformation with respect to time and has been found to
reflect myocardial contractility better than strain parame-
ters, which are more pre-load and after-load dependent
and may change with ventricular dimensions [32, 33].
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Fig. 4 Kaplan Meyer survival curves for survival free of the combined endpoint according to CMR global RV strain parameters
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shortening [34]; however, it has been suggested that trans-
verse wall motion may be a better reflection of systolic func-
tion in PH than longitudinal motion, and it is possible that
as PH advances and the RV becomes more hypertrophic, cir-
cumferential deformation becomes relatively more important
resembling LV contractility patterns [35]. In addition, we
have previously demonstrated heterogeneity of regional RV
function in PH even before RVEF decreases [36]. Thus,
evaluating RV myocardial deformation may identify subclin-
ical RV dysfunction before the development of abnormalities
on conventional measures of RV performance. Further evi-
dence that strain reflects RV performance beyond RVEF
(similar to findings in the LV) is the independent value of
strain when adjusting for RVEF shown in this study.
Limitations
This was a single-center, retrospective study performed at
a large tertiary hospital, so the inherent limitations of this
study design cannot be avoided, specifically the possibil-
ities of referral bias and residual confounding. We tried to
limit sample heterogeneity by including only patients in
PH Group 1 and Group 5 but etiologies of PH and under-
lying conditions still varied, thus we cannot exclude the
possibility that other diseases influenced RV strain. How-
ever, this reflects the clinical reality of a relatively rare
disorder. Although the number of events was rather large
at 78, we were unable to include every single variable asso-
ciated with outcomes in the multivariate models.
Nonetheless, we could find significant associations be-
tween RV strain parameters and events risk after adjusting
for 6 clinically and prognostically relevant covariates. The
control group was not free of disease, a fact that could
interfere with the strain values. Nevertheless, biventricular
volumes and ejection fractions were normal, and no LGE
was noted in these patients except one focal case at the
RV insertion point in a patient with scleroderma. CMR
and RHC were not performed simultaneously, which may
reduce the associations between hemodynamic parameters
and RV deformation; however, the interval between the 2
exams was not more than 1 month. The temporal reso-
lution of the CMR cine images (33–45 ms) was lower than
commonly recommended for strain rate evaluation; there-
fore, true strain rate values are likely underestimated. Fi-
nally, the CMR-FT strain analysis software used in this
study was designed primarily for LV strain analysis and
adapted for use on the RV; strain analysis software specific
to RV has yet to be developed.
Conclusions
CMR-FT assessment of RV strain can be successfully incor-
porated into a comprehensive CMR exam protocol for PH
and may represent a valuable noninvasive method of evalu-
ation that could be widely adopted at PH centers. Routine
RV strain measurement using CMR-FT is feasible in PH
patients, correlates with disease severity, and is associated
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Fig. 5 Cox survival curve for survival free of the combined endpoint according to CMR global RV strain parameter cutoff point. GCSR cut off
point > -0.8 s-1 was able to predict events in the multivariate model
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